ESR1 and breast carcinoma: In ER+ breast cancer cell lines, elevated levels of miR-18a modulate cell polarity, leading to activation of the Wnt pathway and actin remodeling, which may underlie the poor prognosis observed in ER+ breast tumors in clinical settings[135].